Psycheceutical Bioscience Inc

OTC:BWVI

Blue Water Ventures International, Inc. engages in the exploration, discovery, and recovery of historical cultural artifacts, cargo and treasure from ocean shipwrecks. The company is headquartered in Fleming Island, Florida and currently employs 28 full-time employees. The company went IPO on 2007-05-25. The firm is engaged in developing cutting-edge delivery technologies to support safe psychedelic pharmaceutical medicines. The firm's technology is intended to deliver compounds across the blood-brain barrier while bypassing the gastrointestinal (GI) tract and liver, eliminating hallucinogenic effects and vastly reducing exposure to drug toxicities and side effects. The firm's systematic delivery system is designed to use extremely small multi-layered compounds, called Janus particles, to deliver targeted doses of any psychedelic compound directly through the blood-brain barrier, thereby bypassing the liver and reducing toxicity and side effects. The firm's NeuroDirect topical delivery system is a non-systemic delivery technology designed to deliver neuro-active compounds directly into the nerve tissue via topical application at the back of the neck.